Website maintenance is planned from 8:00 a.m. CDT Saturday, July 27, through 9:00 p.m. CDT Sunday, July 28. Brief disruptions may occur during this time.
Use of acetyl cholinesterase inhibitors in mild to moderate dementia or N-methyl-D-aspartate antagonists in moderate to severe dementia may help with BPSD but have not been shown to prolong life. Once an individual is institutionalized, review of the risks and benefits of the medications should be reviewed periodically and deprescribed when no longer demonstrating benefit to the patient. Acetyl cholinesterase inhibitors can worsen anorexia and N-methyl-D-aspartate receptor agonists are not indicated with severe renal insufficiency, both of which could be present in the older population.